Business Standard

Sunday, December 29, 2024 | 11:12 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covid-19 treatment: AIIMS to conduct clinical trials of plasma therapy

The AIIMS director stresses on the need to have good and well-conducted research trials before the therapy is recommended for routine use

AIIMS
Premium

It is necessary for all institutes to take necessary approvals from the Indian Council of Medical Research (ICMR) and DCGI and follow proper clinical practice guidelines for this research. AIIMS. Photo: PTI

BS Web TeamAgencies
The All India Institute of Medical Sciences is planning to conduct a clinical trial of the convalescent plasma therapy in the treatment of Covid-19 patients, AIIMS Director Dr Randeep Guleria said on Tuesday. The modalities of taking the approval from the Drug Controller General of India (DCGI) is being worked out, official sources said.

Stating that the mode of treatment in Covid-19 is still at an "experimental stage", Guleria stressed on the need to have good and well-conducted research trials before its benefit, and this mode of therapy can be recommended for routine use in coronavirus patients. "AIIMS is working with the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in